Countries Australia
Parnell Pharmaceuticals Acquires Noble Pharma LLC To Strengthen US Manufacturing Capabilities
Parnell announced the acquisition of Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, according to the Securities Purchase Agreement dated Novem...
April 10, 2026 | News
Lumonus And Memorial Sloan Kettering Cancer Center Collaborate To Scale Automated Radiation Therapy Planning
Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, announced a collaboration wit...
April 09, 2026 | News
Earendil Labs Advances HXN 1001 With First Patient Dosed In Phase IIa Ulcerative Colitis Trial
Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, announced the first patient has been dosed in a Phase IIa clin...
April 06, 2026 | News
Agenus Inc. Initiates Landmark Phase 3 BATTMAN Trial In MSS Metastatic Colorectal Cancer
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer Cases Color...
April 03, 2026 | News
Delonix Bioworks Initiates First In Human Trial Of DX 104 For Meningococcal B Vaccine
Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-h...
April 01, 2026 | News
Organon Asia Pacific Announces 2026 Her Health Grant Recipients To Advance Women’s Health Access
Organon Asia Pacific Cluster today announced the 2026 Her Health Grant recipients for the Asia Pacific region, marking a significant milestone in efforts t...
March 31, 2026 | News
Eisai And Nuvation Bio Advance Taletrectinib With EMA Validation For ROS1 Positive Lung Cancer
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”), a human-centered global leading research-based pharmaceutical company w...
March 30, 2026 | News
Clarity Pharmaceuticals Signs Copper 64 Supply Agreement With Theragenics To Advance Radiopharmaceutical Commercialisation
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation pr...
March 27, 2026 | News
Celosia Therapeutics Initiates Phase 1b Trial Of CTx1000 Targeting TDP 43 In ALS
CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS Celosia Therapeutics, an Australian biotech company developing advanced gen...
March 25, 2026 | News
Monash University And ClinChoice Partner To Accelerate Early Phase Clinical Trials
Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, announced a strate...
March 23, 2026 | News
Australia Grants CTA For First In Human KMCAR T Cell Therapy Targeting Multiple Myeloma
Clinical Trial Approval (CTA) granted by Australia’s Therapeutic Goods Administration (TGA) for KMCAR™ T-cell, a first-in-human CAR-T cell th...
March 18, 2026 | News
BioCina Advances RLS 2201 With CMC Programme To Enable Clinical Entry
BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC (Chemistry,...
March 18, 2026 | News
Australian Researchers Launch Clinical Trial Exploring Hyperbaric Oxygen Therapy For High Grade Glioma
Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating ...
March 17, 2026 | News
Telix Resubmits US NDA For Pixclara PET Imaging Agent Targeting Glioma Diagnosis
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food ...
March 17, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
